Actuarial escape velocity: Difference between revisions

Jump to navigation Jump to search
No edit summary
 
No edit summary
Line 1: Line 1:
{{SI}}
{{EH}}
'''Actuarial escape velocity''' is a concept first publicly proposed by David Gobel, founder of the [[Methuselah Mouse Prize|Methuselah Foundation]].  It refers to a point in time at which the acceleration of advances in [[biomedical technology]] surpass the rate at which humans [[senescence|age]] — in other words, the point at which, each year, the average human [[life expectancy]] increases by at least one year.  This makes actuarial escape velocity an attractive idea, as a means of achieving [[indefinite lifespan]].<ref>{{cite journal
'''Actuarial escape velocity''' is a concept first publicly proposed by David Gobel, founder of the [[Methuselah Mouse Prize|Methuselah Foundation]].  It refers to a point in time at which the acceleration of advances in [[biomedical technology]] surpass the rate at which humans [[senescence|age]] — in other words, the point at which, each year, the average human [[life expectancy]] increases by at least one year.  This makes actuarial escape velocity an attractive idea, as a means of achieving [[indefinite lifespan]].<ref>{{cite journal
   | last = de Grey
   | last = de Grey
Line 21: Line 24:
==References==
==References==
<references/>
<references/>
{{med-stub}}


[[Category:Life extension]]
[[Category:Life extension]]
Line 28: Line 29:
[[Category:Bioengineering]]
[[Category:Bioengineering]]
[[Category:Science fiction themes]]
[[Category:Science fiction themes]]
{{SIB}}
{{WH}}
{{WS}}

Revision as of 15:20, 9 April 2009

WikiDoc Resources for Actuarial escape velocity

Articles

Most recent articles on Actuarial escape velocity

Most cited articles on Actuarial escape velocity

Review articles on Actuarial escape velocity

Articles on Actuarial escape velocity in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Actuarial escape velocity

Images of Actuarial escape velocity

Photos of Actuarial escape velocity

Podcasts & MP3s on Actuarial escape velocity

Videos on Actuarial escape velocity

Evidence Based Medicine

Cochrane Collaboration on Actuarial escape velocity

Bandolier on Actuarial escape velocity

TRIP on Actuarial escape velocity

Clinical Trials

Ongoing Trials on Actuarial escape velocity at Clinical Trials.gov

Trial results on Actuarial escape velocity

Clinical Trials on Actuarial escape velocity at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Actuarial escape velocity

NICE Guidance on Actuarial escape velocity

NHS PRODIGY Guidance

FDA on Actuarial escape velocity

CDC on Actuarial escape velocity

Books

Books on Actuarial escape velocity

News

Actuarial escape velocity in the news

Be alerted to news on Actuarial escape velocity

News trends on Actuarial escape velocity

Commentary

Blogs on Actuarial escape velocity

Definitions

Definitions of Actuarial escape velocity

Patient Resources / Community

Patient resources on Actuarial escape velocity

Discussion groups on Actuarial escape velocity

Patient Handouts on Actuarial escape velocity

Directions to Hospitals Treating Actuarial escape velocity

Risk calculators and risk factors for Actuarial escape velocity

Healthcare Provider Resources

Symptoms of Actuarial escape velocity

Causes & Risk Factors for Actuarial escape velocity

Diagnostic studies for Actuarial escape velocity

Treatment of Actuarial escape velocity

Continuing Medical Education (CME)

CME Programs on Actuarial escape velocity

International

Actuarial escape velocity en Espanol

Actuarial escape velocity en Francais

Business

Actuarial escape velocity in the Marketplace

Patents on Actuarial escape velocity

Experimental / Informatics

List of terms related to Actuarial escape velocity

Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [1] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.

Actuarial escape velocity is a concept first publicly proposed by David Gobel, founder of the Methuselah Foundation. It refers to a point in time at which the acceleration of advances in biomedical technology surpass the rate at which humans age — in other words, the point at which, each year, the average human life expectancy increases by at least one year. This makes actuarial escape velocity an attractive idea, as a means of achieving indefinite lifespan.[1]

Controversial biogerontologist Aubrey de Grey and futurist Ray Kurzweil have championed the idea, claiming that if we begin attempting to push the limits of aging science right now instead of continuing forward at a relatively leisurely pace, we will be saving more lives in the future even if it doesn't seem that way now. For instance, even if it starts to look as though we won't cure aging within the lifetimes of anybody alive today, to not push forward with all speed because of this is to condemn perhaps billions of people to needless aging and death a hundred or more years hence, when hastened research practices today could have made the difference ahead of time.

See also

References

  1. de Grey, Aubrey D. N. J. (June 15, 2004). "Escape Velocity: Why the Prospect of Extreme Human Life Extension Matters Now". PLoS Biol. 2 (6): 723–726. Retrieved 2007-02-12.

Template:SIB

Template:WH Template:WS